Linda Prescott

72F · SH-10302OFF

Cardiac (HFpEF) · Retired (teacher)

Next consult

Sat 18 Apr, 11:00

Gray zone· p 0.52Steady

Trajectory headline

Trajectory stable but under-characterised. Uncertainty volume is large — confidence uplift is the right next move, not treatment change.

Model priority

Gray zone · pattern emerging

Biggest single change you could makeAdd GLP-1 → −33% (BMI)

Patient Context Card · AIME

Brief

Trajectory-grounded orientation for today's appointment.

HFpEF trajectory is stable, but the model is under-informed. Two tests would sharpen the picture materially.

Trajectory narrative

Linda has not decompensated in 14 months and her symptoms on last review were unchanged. The trajectory burden is modest, but the 10-year envelope is wide — Horizon-1 confidence is 20/40, mainly because NT-proBNP has never been measured and the last echocardiogram is five years old. The correct action is to tighten the model rather than add therapy.

Active concerns

HFpEF — preserved EF on last echo (2021)
SBP averaging 138 on clinic readings
BMI 29.8
Recurrent ankle swelling — reported by family, not formally documented

Suggested consultation focus

Order NT-proBNP + ferritin/TSAT today
Refer for repeat echocardiogram (diastolic function + LVH)
Discuss patient-app connection — continuous weight + BP would be high-value
Defer SGLT2 pending confirmation of HFpEF diagnosis

Supporting record context

Current medications

Bisoprolol 2.5mg · Ramipril 5mg · Furosemide 20mg PRN

Allergies

NKDA

Social

Widowed, lives alone, good functional status

For demonstration purposes. Not a diagnostic tool.

Horizon-1 · Syndrome activation

Latent clinical states

Output of the dynamic hypergraph. Direction = trajectory on that axis.

HF (preserved EF)

0.48

Metabolic (age-associated)

0.41

For demonstration purposes. Not a diagnostic tool.

← Practice Horizon

Linda Prescott

72F · SH-10302OFF

Cardiac (HFpEF) · Retired (teacher)

Next consult

Sat 18 Apr, 11:00

Gray zone· p 0.52Steady

Trajectory headline

Trajectory stable but under-characterised. Uncertainty volume is large — confidence uplift is the right next move, not treatment change.

Model priority

Gray zone · pattern emerging

Biggest single change you could makeAdd GLP-1 → −33% (BMI)

Patient Context Card · AIME

Brief

Trajectory-grounded orientation for today's appointment.

HFpEF trajectory is stable, but the model is under-informed. Two tests would sharpen the picture materially.

Trajectory narrative

Active concerns

HFpEF — preserved EF on last echo (2021)
SBP averaging 138 on clinic readings
BMI 29.8
Recurrent ankle swelling — reported by family, not formally documented

Suggested consultation focus

Order NT-proBNP + ferritin/TSAT today
Refer for repeat echocardiogram (diastolic function + LVH)
Discuss patient-app connection — continuous weight + BP would be high-value
Defer SGLT2 pending confirmation of HFpEF diagnosis

Supporting record context

Current medications

Bisoprolol 2.5mg · Ramipril 5mg · Furosemide 20mg PRN

Allergies

NKDA

Social

Widowed, lives alone, good functional status

For demonstration purposes. Not a diagnostic tool.

Horizon-1 · Syndrome activation

Latent clinical states

Output of the dynamic hypergraph. Direction = trajectory on that axis.

HF (preserved EF)

0.48

Metabolic (age-associated)

0.41

For demonstration purposes. Not a diagnostic tool.